HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

1,3-dipropyl-8-(3-noradamantyl)xanthine

selective antagonist for adenosine receptors; a cardiovascular agent
Also Known As:
1,3-DNAX; 8-(3-noradamantyl)-1,3-dipropylxanthine; 8-(noradamantan-3-yl)-1,3-dipropylxanthine; KW 3902; KW-3902; MK 7418; MK-7418; MK7418; rolofylline
Networked: 41 relevant articles (8 outcomes, 15 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Cotter, Gad: 13 articles (05/2015 - 10/2008)
2. Metra, Marco: 13 articles (05/2015 - 10/2008)
3. Givertz, Michael M: 13 articles (05/2015 - 10/2007)
4. Ponikowski, Piotr: 12 articles (05/2015 - 01/2010)
5. O'Connor, Christopher M: 12 articles (05/2015 - 10/2008)
6. Massie, Barry M: 12 articles (05/2015 - 10/2007)
7. Dittrich, Howard C: 10 articles (05/2015 - 10/2007)
8. Cleland, John G F: 9 articles (05/2015 - 08/2006)
9. Teerlink, John R: 9 articles (05/2015 - 10/2010)
10. Voors, Adriaan A: 8 articles (05/2015 - 05/2011)

Related Diseases

1. Acute Kidney Injury (Acute Renal Failure)
2. Heart Failure
3. Dyspnea (Shortness of Breath)
4. Anoxia (Hypoxia)
5. Seizures (Seizure)

Related Drugs and Biologics

1. Adenosine
2. Purinergic P1 Receptors (Adenosine Receptor)
3. Relaxin
4. Brain Natriuretic Peptide (Natrecor)
5. Vasopressins (Vasopressin)
6. tolvaptan
7. Glycerol (Glycerine)
8. Gentamicins (Gentamicin)
9. Contrast Media
10. Cisplatin (Platino)

Related Therapies and Procedures

1. Injections
2. Stents
3. Drug-Eluting Stents